Ireland’s first conference on healthcare outcomes took place in the Healthcare Outcomes Research Centre, supported by Novartis. The aim of the conference was to facilitate a discussion about the role of healthcare outcomes data in the development and implementation of health policy.
Professor Jan Sorensen, Director of the Healthcare Research Outcomes Centre at RCSI said, “Five years ago there was little discussion in Ireland about the importance of healthcare outcomes data in policy development. What we would encourage now is that the use of outcomes data becomes an integral part of decision-making in every part of the health service, resulting in better outcomes for patients and the more efficient delivery of health services”.
Loretto Callaghan, Managing Director, Novartis stated, “We are delighted to support Ireland’s first national conference on healthcare outcomes. Healthcare systems around the world are facing growing demands, which, if unaddressed, could double health spend by 2060, making it unsustainable. Novartis believes a value-based approach is the best way to meet the shared goal of affordable access to healthcare, while improving patient outcomes. We are committed to a focus on health outcomes, and have begun to lead this change, through a number of pilots around the world, including Ireland”.